benfluorex has been researched along with Pulmonary Hypertension in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Benfluorex is a fenfluramine derivative which has been marketed between 1976 and 2009." | 5.46 | Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report. ( Banfi, C; Baufreton, C; Bruneval, P; Ennezat, PV; Fouquet, O; Giraud, R; Rousselet, MC, 2017) |
| "Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its derivatives known to be a cause of pulmonary arterial hypertension (PAH)." | 5.38 | Pulmonary hypertension associated with benfluorex exposure. ( Bergot, E; Bourdin, A; Chaumais, MC; Cottin, V; Dromer, C; Frachon, I; Habib, G; Humbert, M; Jaïs, X; Lamblin, N; Montani, D; Pison, C; Poubeau, P; Prevot, G; Reynaud-Gaubert, M; Sanchez, O; Savale, L; Simonneau, G; Sitbon, O; Tubert-Bitter, P, 2012) |
| " Further studies should be conducted to determine the subsequent course of benfluorex-induced VHD and PAH, and to identify genetic, biological and clinical factors that determine individual susceptibility to developing such adverse effects." | 2.50 | Adverse effects of benfluorex on heart valves and pulmonary circulation. ( Andréjak, M; Maréchaux, S; Peltier, M; Szymanski, C; Tribouilloy, C, 2014) |
| "Benfluorex is a fenfluramine derivative which has been marketed between 1976 and 2009." | 1.46 | Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report. ( Banfi, C; Baufreton, C; Bruneval, P; Ennezat, PV; Fouquet, O; Giraud, R; Rousselet, MC, 2017) |
| "Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its derivatives known to be a cause of pulmonary arterial hypertension (PAH)." | 1.38 | Pulmonary hypertension associated with benfluorex exposure. ( Bergot, E; Bourdin, A; Chaumais, MC; Cottin, V; Dromer, C; Frachon, I; Habib, G; Humbert, M; Jaïs, X; Lamblin, N; Montani, D; Pison, C; Poubeau, P; Prevot, G; Reynaud-Gaubert, M; Sanchez, O; Savale, L; Simonneau, G; Sitbon, O; Tubert-Bitter, P, 2012) |
| "Benfluorex is an amphetamine appetite suppressant derived from fenfluramine." | 1.36 | Benfluorex: increasing reports of valve disorders. ( , 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szymanski, C | 1 |
| Andréjak, M | 1 |
| Peltier, M | 1 |
| Maréchaux, S | 2 |
| Tribouilloy, C | 2 |
| Baufreton, C | 1 |
| Bruneval, P | 1 |
| Rousselet, MC | 1 |
| Ennezat, PV | 1 |
| Fouquet, O | 1 |
| Giraud, R | 1 |
| Banfi, C | 1 |
| Gueffet, JP | 2 |
| Piriou, N | 1 |
| Trochu, JN | 1 |
| Droogmans, S | 1 |
| Cosyns, B | 1 |
| Van Camp, G | 1 |
| Le Ven, F | 1 |
| Habib, G | 2 |
| Eicher, JC | 1 |
| Blanchard-Lemoine, B | 1 |
| Rousseau, J | 1 |
| Hénon, P | 1 |
| Jobic, Y | 1 |
| Etienne, Y | 1 |
| Nau, JY | 1 |
| Savale, L | 1 |
| Chaumais, MC | 1 |
| Cottin, V | 1 |
| Bergot, E | 1 |
| Frachon, I | 1 |
| Prevot, G | 1 |
| Pison, C | 1 |
| Dromer, C | 1 |
| Poubeau, P | 1 |
| Lamblin, N | 1 |
| Reynaud-Gaubert, M | 1 |
| Bourdin, A | 1 |
| Sanchez, O | 1 |
| Tubert-Bitter, P | 1 |
| Jaïs, X | 1 |
| Montani, D | 1 |
| Sitbon, O | 1 |
| Simonneau, G | 1 |
| Humbert, M | 1 |
1 review available for benfluorex and Pulmonary Hypertension
| Article | Year |
|---|---|
Adverse effects of benfluorex on heart valves and pulmonary circulation.
Topics: Echocardiography; Fenfluramine; Heart Valve Diseases; Heart Valves; Humans; Hypertension, Pulmonary; | 2014 |
9 other studies available for benfluorex and Pulmonary Hypertension
| Article | Year |
|---|---|
Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
Topics: Appetite Depressants; Fatal Outcome; Female; Fenfluramine; Heart Valve Diseases; Heart Valve Prosthe | 2017 |
Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
Topics: Appetite Depressants; Fenfluramine; France; Heart Valve Diseases; Humans; Hypertension, Pulmonary; N | 2009 |
Benfluorex: increasing reports of valve disorders.
Topics: Appetite Depressants; Fenfluramine; France; Heart Valve Diseases; Humans; Hypertension, Pulmonary; P | 2010 |
Valvular heart disease associated with benfluorex.
Topics: Appetite Depressants; Diuretics; Echocardiography, Doppler, Color; Female; Fenfluramine; Furosemide; | 2010 |
Benfluorex: the last chapter of drug-induced valvular heart disease?
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Appetite Depressants; Europe; Fenfluramine; France; | 2011 |
Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.
Topics: Appetite Depressants; Body Mass Index; Comorbidity; Dose-Response Relationship, Drug; Echocardiograp | 2011 |
Benfluorex: how many deaths?
Topics: Appetite Depressants; Familial Primary Pulmonary Hypertension; Fenfluramine; France; Heart Valve Dis | 2011 |
[The French are wary of their drugs].
Topics: Appetite Depressants; Body Mass Index; Cause of Death; Drugs, Generic; Fenfluramine; France; Heart V | 2011 |
Pulmonary hypertension associated with benfluorex exposure.
Topics: Adult; Aged; Appetite Depressants; Familial Primary Pulmonary Hypertension; Female; Fenfluramine; Hu | 2012 |